Suppr超能文献

不含血管性血友病因子的生物活性低分子量人抗血友病因子的部分纯化。II. 用硫醇-二硫键交换色谱法进一步纯化及二硫键易受有限还原影响的更多证据

Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. II. Further purification with thiol-disulfide interchange chromatography and additional evidence for disulfide bonds susceptible to limited reduction.

作者信息

Harris R B, Johnson A J, Hodgins L T

出版信息

Biochim Biophys Acta. 1981 May 29;668(3):471-80. doi: 10.1016/0005-2795(81)90181-1.

Abstract

Thiol-disulfide interchange chromatography was used in the preparation of partially purified (approx. 17 000-fold) low molecular weight, Mr approximately or equal to 115 000, human antihemophilic factor essentially free of Von Willebrand factor. This antihemophilic factor was prepared from fresh plasma which had undergone limited reduction with 1 mM dithiothreitol and was subsequently reacted with 2,2'-dipyridyl disulfide, a sulfhydryl reagent which readily undergoes disulfide exchange. Exchange of protein-2-pyridyl mixed disulfide with thiopropyl-Sepharose resulted in the chromatographic adsorption of approx. 96% of the coagulant activity, of which approx. 20% subsequently eluted with 1.0 mM dithiothreitol. After reductive displacement from the thiopropyl-Sepharose the antihemophilic factor could be S-alkylated with iodo-[1-14]acetamide. The ratio of coagulant activity to Von Willebrand factor-antigen activity was greater than 30 000 : 1. In contrast, reduced antihemophilic factor was alkylated with iodoacetamide prior to chromatography as a control, and showed no exchange with the thiopropyl-Sepharose, eluting quantitatively in the breakthrough volume. These studies reinforce our previous results (Harris, R.B., Newman, J. and Johnson, A.J. (1981) Biochim. Biophys. Acta 668, 456-470) that partial reduction with dithiothreitol exposes critical sulfhydryl groups which, when alkylated, maintains the antihemophilic factor in a low molecular weight form without inactivating procoagulant activity.

摘要

硫醇 - 二硫键交换色谱法用于制备部分纯化(约17000倍)的低分子量、Mr约等于115000的人抗血友病因子,该因子基本不含血管性血友病因子。这种抗血友病因子是从新鲜血浆中制备的,新鲜血浆先用1 mM二硫苏糖醇进行有限还原,随后与2,2'-二吡啶二硫化物反应,2,2'-二吡啶二硫化物是一种容易进行二硫键交换的巯基试剂。蛋白质 - 2 - 吡啶混合二硫化物与硫丙基 - 琼脂糖的交换导致约96%的凝血活性发生色谱吸附,其中约20%随后用1.0 mM二硫苏糖醇洗脱。从硫丙基 - 琼脂糖上进行还原置换后,抗血友病因子可用碘代[1 - 14]乙酰胺进行S - 烷基化。凝血活性与血管性血友病因子 - 抗原活性的比值大于30000 : 1。相比之下,作为对照,还原后的抗血友病因子在色谱分离前用碘乙酰胺进行烷基化,未显示与硫丙基 - 琼脂糖发生交换,在穿透体积中定量洗脱。这些研究强化了我们之前的结果(哈里斯,R.B.,纽曼,J.和约翰逊,A.J.(1981年)《生物化学与生物物理学报》668,456 - 470),即二硫苏糖醇的部分还原会暴露关键的巯基,烷基化时能使抗血友病因子保持低分子量形式且不使促凝血活性失活。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验